European Archives - Page 168 of 1214 - European Medical Journal

Nursing Homes Identified as Hubs for Drug-Resistant Pathogens

New research highlights the role of ventilator-capable nursing homes in the spread of antimicrobial-resistant pathogens, including the emerging multidrug-resistant fungus Candida auris.

Rethinking Bladder Drug Choices: Dementia Risk in Older Adults

Danish study finds anticholinergic bladder drugs linked to dementia risk, but not when compared to mirabegron.

Exploring Microbial Dysbiosis in Atopic Dermatitis Treatment

This study aimed to compare the effects of antimicrobial–corticosteroid combination therapy with corticosteroid monotherapy.

Leiomyosarcoma in Post-Embolised Angiomyolipoma

Sarcomatous transformation of the angiomyolipoma (AML) is a rare event with a handful of cases reported in the literature.¹ It is marked by…

Managing Factor Xa Inhibitors Perioperatively: PERIXa Shows Promise

New study finds the PERIXa protocol for perioperative anticoagulation in AF patients undergoing low-risk procedures is safe.

Exploring Bladder Preservation in Muscle-Invasive Bladder Cancer Treatment

The combination of durvalumab and tremelimumab with concurrent radiotherapy is a feasible and safe treatment strategy.

Early Lung Function Decline Predicts Long-Term Respiratory Symptoms

Individuals with impaired lung function trajectories experience a higher burden of respiratory symptoms, including wheeze and phlegm.

New Evidence Supports PPI Co-Prescription in Patients with AMI Undergoing PCI

PPIs significantly reduce gastrointestinal bleeding risk in AMI patients on DAPT without increasing cardiovascular events. Read more on clinical implications.

High-Risk Genetic Markers Predict Poor Outcomes in Multiple Myeloma

Multiple myeloma patients with two or more high-risk genetic abnormalities face significantly poorer outcomes, regardless of disease stage or treatment.

Study Shows Primary Care and Telehealth Can Provide Effective Diabetes Care

People with Type 1 diabetes can achieve the same positive outcomes using advanced insulin technology when trained by their PCPs or through telehealth as they would by visiting a specialist in person according to new study.